Valeant (VRX), DepoMed (DEPO) Sue Watson (WPI) Over Generic Glumetza

April 18, 2012 2:44 PM EDT Send to a Friend
Bloomberg reporting Valent Pharma (NYSE: VRX) and DepoMed (Nasdaq: DEPO) have sued Watson (NYSE: WPI), challenging the company's generic glumetza product.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Litigation

Add Your Comment